Table of Content

1. What is Photodynamic Cancer Therapy?

1.1 Overview
1.2 Advantage of Photodynamic Cancer Therapy
1.3 Evolution of the Photodynamic Cancer Therapy


2. Why There Exist Need for Photodynamic Therapy For Cancer Treatment?

3. The Procedural Framework For Photodynamic Cancer Therapy

3.1 Procedure for Photodynamic Therapy
3.2 Administering Photosensitizers To Body
3.3 Oxygen - The Vital Substrate in Photodynamic Therapy
3.4 Light Source - For Safe & Effective Activation of the Photosensitizer


4. Improving The Photodynamic Therapy Efficacy Through Photosensitizer Delivery

4.1 Role of Organic Nano Particles: Amplified Drug Loading & Increasing The Solubility
4.2 Inorganic Nanocarrier of Photosensitizers in Photodynamic Therapy


5. Anti-Tumor Activity of the Photodynamic Therapy

5.1 Direct Tumor Photodynamic Therapy Damage
5.2 Vascular Damage
5.3 Inflammatory & Immune Response




6. Multiple Cancer Treatments Using Photodynamic Therapy

6.1 Non-Melanoma Skin Cancer
6.2 Prostate Cancer
6.3 Breast Cancer
6.4 Brain Tumor
6.5 Lung Cancer
6.6 Head & Neck Cancer
6.7 Oral Lesions & Oesophageal Cancer
6.8 Cervical Cancer
6.9 Colorectal Cancer
6.10 Cancer of the Bile Duct and the Pancreas


7. Combinational Photodynamic Cancer Therapy - Step Towards Complete Eradication Of Tumor Growth


8. Advancements in the Photodynamic Therapy Segment

8.1 Intracellular “Activated” Two-Photon photodynamic Therapy for Breast Cancer
8.2 Gold Nano-Clusters: A New Nanotech Innovation for Photodynamic Therapy.
8.3 Photodynamic Therapy & Combinational Therapy using Microbial Adjuvants & Cytokines


9. Global Cancer Photosensitisers Clinical Pipeline Overview

9.1 By Phase
9.2 By Country
9.3 By Company


10. Global Cancer Photosensitisers Clinical Pipeline By Company, Indication & Phase

10.1 Research
10.2 Preclinical
10.3 Phase-II
10.4 Phase-III


11. Marketed Cancer Photosensitisers By Company & Indication

11.1 Ameluz
11.2 UVADEX
11.3 Photobarr/ Photofrin
11.4 Foscan
11.5 Cevira
11.6 Metvix
11.7 TOOKAD Soluble
11.8 Aptocine/ Laserphyrin/ Leserfin/ Litx


12. Commercial Information Revealing the Industry In-sights for Photodynamic Therapy

12.1 Advancing the Photodynamic Therapy by a Novel Compound
12.2 Adaption of New Techniques for Making Photodynamic Therapy Effective & More Ceaper
12.3 Replacing Oxygen Dependent Drugs with More Efficient Compounds
12.4 Researchers Revolutionizing the Era of Surgical Injections into Gels


13. Global Photodynamic Therapy Market: Current Scenario & its Role in the Oncology Segment

13.1 Global Photodynamic Therapy Market Analysis
13.2 North America
13.3 Europe
13.4 Asia Pacific
13.5 Latin America, Middle East & Africa


14. Global Photodynamic Cancer Therapy Market Dynamics

14.1 Favorable Parameters for the Growth
14.2 Challenges to Future Market Growth


15. Global Photodynamic Cancer Therapy Market Future Outlook


16. Competitive Landscape

16.1 Theralase Technologies
16.2 Dusa Pharmaceuticals
16.3 Biofrontera AG
16.4 Soligenix
16.5 Coherent
16.6 Lumenis
16.7 Nanoprobes
16.8 PhotoMedex
16.9 Biolitec
16.10 Ambicare Health
16.11 Quest Pharma Tech
16.12 Photolitec
 



List of Figures


Figure 1-1: Superiority of Cancer Photodynamic Therapy over Other Methods
Figure 1-2: Evolution of Photodynamic Therapy

Figure 2-1: The Need for Cancer Photodynamic Therapy
Figure 3-1: Working Principle of Photodynamic Therapy
Figure 3-2 : Desired Features of an Ideal Photosensitizer
Figure 3-3 : Cellular Mechanism of Photodynamic Therapy
Figure 3-4: Various Types of Light Sources Used in Photodynamic Therapy

Figure 4-1: Drug Carriers for Photodynamic Therapy
Figure 4-2 : Delivery of Photosensitizer Drugs Using Liposomes
Figure 4-3: Structure of a Quantum Dot
Figure 4-4: Gold Nanoparticles for Targeted Delivery of Photosensitizers

Figure 5-1: Apoptosis of Tumor Cell Induced by Photodynamic Therapy
Figure 5-2 : Vascular Damage of Tumor Cells Induced By Photodynamic Cancer Therapy
Figure 5-3 : Tumor Cell Death Pathways by Reactive Oxygen Species

Figure 6-1 : Photodynamic Therapy for Lung Cancer
Figure 6-2 : Photodynamic Therapy for the treatment of Cervical Cancer

Figure 7-1 : Limitation of Cancer Photodynamic Therapy

Figure 9-1: Global - Cancer Photosensitisers Clinical Pipeline by Phase (Numbers), 2020 till 2026
Figure 9-2: Global - Cancer Photosensitisers Clinical Pipeline by Phase (%), 2020 till 2026
Figure 9-3: Global - Cancer Photosensitisers Clinical Pipeline by Company (Numbers), 2020 till 2026
Figure 9-4: Global - Cancer Photosensitisers Clinical Pipeline by Company (Numbers), 2020 till 2026

Figure 13-1: Use of Photodynamic Therapy for Various Skin Cancer Types
Figure 13-2: Global – Cancer Photodynamic Therapy Market Opportunity (US$ Billion), 2018-2026
Figure 13-3: Global - Cancer Photodynamic Therapy Shares by Devices and Essentials
Figure 13-4: Global - Share of Cancer In Photodynamic Therapy (%), 2019
Figure 13-5: Global - Share of Cancer In Photodynamic Therapy (%), 2026
Figure 13-6: Global - Cancer Photodynamic Therapy by Region (%), 2019
Figure 13-7: Global - Cancer Photodynamic Therapy by Region (%), 2026
Figure 13-8: US – Cancer Photodynamic Therapy Market Opportunity (US$ Billion), 2018 & 2026
Figure 13-9: Europe – Cancer Photodynamic Therapy Market Opportunity (US$ Billion), 2018 & 2026
Figure 13-10: Asia – Cancer Photodynamic Therapy Market Opportunity (US$ Billion), 2018 & 2026

Figure 14-1: Global - Driving Factors of the Cancer Photodynamic Therapy Market
Figure 14-2: Global - Breast, Lung & Skin Cancer Statistics
Figure 14-3: Global – Cancer Photodynamic Therapy Market Challenges
Figure 14-4 : Global - Scientific Limitations of the Cancer Photodynamic therapy
Figure 14-5 : Global - Commercial Challenges to the Photodynamic Therapy Market

Figure 15-1: Global - Future Governing Factors of the Photodynamic Therapy Marke